Diphtheria Tetanus Pertussis and Haemophilus influenzae type b Conjugate Vaccine
Diphtheria, tetanus, pertussis and (+) Haemophilus influenzae type b conjugate vaccine (adsorbed)
Product Details
WHO Product ID
FVP-P-216
Status
Prequalified
Vaccine type
Diphtheria, tetanus, pertussis and (+) Haemophilus influenzae type b conjugate vaccine (adsorbed)
Abbreviated Name
DTwP+Hib
Commercial Name
Diphtheria Tetanus Pertussis and Haemophilus influenzae type b Conjugate Vaccine
PQ Holder
Serum Institute of India Pvt. Ltd.
212/2 Off Soli Poonawala Road, Hadaspar
Pune,
Maharashtra
411 028
India
Responsible NRA
Central Drugs Standard Control Organization (CDSCO)
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with liquid active component before use
Presentation
Vial + Ampoule
Number of doses
1
Route of administration
Intramuscular
Vaccine Vial Monitor
Type 14
Multidose Vial Policy
Not applicable
Shelf life (months)
24 months
Storage temperature
2 - 8°C
Diluent
Liquid active component
Preservative
Thiomersal
Preservative concentration
0.01%
Product Packaging
Secondary Container
Tertiary Container
Component Packed
Active (Vaccine)
Total doses
200
Description
Carton (containing 4x50=200 vials of Hib component [Dimensions 18.5x9.5x6.0] and
Dimensions
18.5 x 9.5 x 6.0 cm
Cold Chain Volume (cm³/dose)
5.27
Component Packed
Active (Vaccine)
Total doses
200
Description
4x50=200 ampoules of DTP component) [Dimensions 14.5x6.0x7.0]
Dimensions
14.5 x 6.0 x 7.0 cm
Cold Chain Volume (cm³/dose)
3.05
Component Packed
Active (Vaccine)
Total doses
200
Description
Single dose carton (containing 1 vial of Hib component and one ampoule of DTP component
Cold Chain Volume (cm³/dose)
0.0
